Sanara MedTech P/E Ratio

Sanara MedTech (SMTI) currently reports a P/E ratio of -9.43. That is below the Healthcare sector average of 25.3. Use the charts on this page to explore Sanara MedTech's P/E ratio history and peer comparisons.

Sanara MedTech's P/E ratio of -9.43 is lower than the Healthcare sector average of 25.3. That is roughly 137.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Sanara MedTech's market price to a fundamental measure such as earnings, sales, or book value. At -9.43, SMTI can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -9.43, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.3. From there, open related valuation or income-statement pages for Sanara MedTech, and consider following SMTI for alerts when major investors trade the stock.

Sanara MedTech is classified in the Healthcare sector. On P/E ratio, it currently shows -9.43 versus a sector average near 25.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMTI with unrelated industries.